# Resistance Under the Microscope

> **NCT01441843** · PHASE4 · COMPLETED · sponsor: **Erasmus Medical Center** · enrollment: 400 (actual)

## Conditions studied

- Anxiety

## Interventions

- **DRUG:** Lorazepam
- **DRUG:** NaCl 0.9% (Sodium Chloride)

## Key facts

- **NCT ID:** NCT01441843
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 400 (ACTUAL)
- **Last updated:** 2023-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01441843

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01441843, "Resistance Under the Microscope". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01441843. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*